Profile: Precision Therapeutics deals with the development of decision support tools and services that provide physicians with information for the treatment of cancer patients. Our ChemoFx® is a drug response marker. It is a test that quantifies an individual cancer patient's probable tumor response to various chemotherapeutic and biologic agents, providing both sensitivity & resistance information.

The company has revenues of < USD 1 Million.